SEC Form 4 · accession 0001140361-15-037813
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia J Ladd
Officer — Senior VP and General Counsel
Period of report
Jul 21, 2015
Accepted (ET)
Oct 16, 2015 · 10:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 14, 2015 | P | 3,000 | $12.00 | A | 3,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.6147 | Jul 21, 2015 | A | 246,043 | A | — | Jul 20, 2025 | Common Stock | 246,043 | 246,043 | D |
| Employee Stock Option (right to buy)F2 | $6.6147 | Aug 26, 2015 | A | 27,393 | A | — | Aug 25, 2025 | Common Stock | 27,393 | 27,393 | D |
Explanation of responses
- F1This option vests 25% on June 15, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day the month, except the final installment, which shall vest on June 15, 2019.
- F2This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on October 7, 2015)